4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > 脂肪原/吡咯烷酮A/AG-CN2-0106-C250/250µg
商品详细脂肪原/吡咯烷酮A/AG-CN2-0106-C250/250µg
脂肪原/吡咯烷酮A/AG-CN2-0106-C250/250µg
脂肪原/吡咯烷酮A/AG-CN2-0106-C250/250µg
商品编号: AG-CN2-0106-C250
品牌: Adipogen Inc
市场价: ¥2600.00
美元价: 1560.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
Synonyms(+)-PyripyropeneA;PPPA;FO1289A
ProductTypeChemical
Properties
FormulaC31H37NO10
MW583.6
CAS147444-03-9
Source/HostChemicalsIsolatedfromAspergillusfumigatusFO-1289.
PurityChemicals≥95%(HPLC)
AppearancePalepinktorustybrownsolid.
SolubilitySolubleinmethanol,chloroform,ethylacetateorDMSO.Insolubleinwaterorhexane.
DeclarationManufacturedbyBiOlinksK.K.withcourtesystrainfromTheKitasatoInstitute.
InChiKeyPMMQOFWSZRQWEV-RVTXXDJVSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
Use/StABIlityStableforatleast3yearsafterreceiptwhenstoredat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Antibiotic[1].
  • Highlyspecificinhibitorofacyl-coenzymeA:cholesterolacetyltransferase2(ACAT2)[1-6,8,9].
  • Anti-angiogenic[10].
  • Antiatherogenicandantiatheroscleroticagent.Showscholesterol-loweringandatheroprotectiveactivities.[7,11,12].
ProductReferences
  1. Pyripyropenes,highlypotentinhibitorsofacyl-CoA:cholesterolacyltransferaseproducedbyAspergillusfumigatus:S.Omura,etal.;J.Antibiot.(Tokyo)46,1168(1993)
  2. Pyripyropenes,novelinhibitorsofacyl-CoA:cholesterolacyltransferaseproducedbyAspergillusfumigatus.II.StructureelucidationofpyripyropenesA,B,CandD:Y.K.Kim,etal.;J.Antibiot.(Tokyo)47,154(1994)
  3. Pyripyropenes,novelinhibitorsofacyl-CoA:cholesterolacyltransferaseproducedbyAspergillusfumigatus.I.Production,isolation,andBIOLOGicalproperties:H.Tomoda,etal.;J.Antibiot.(Tokyo)47,148(1994)
  4. Mass-productionofhumanACAT-1andACAT-2toscreenisoform-specificinhibitor:adifferentsubstratespecificityandinhibitoryregulation:K.H.Cho,etal.;BBRC309,864(2003)
  5. IdentificationofACAT1-andACAT2-specificinhibitorsusinganovel,cell-basedfluorescenceassay:individualACATuniqueness:A.T.Lada,etal.;J.LipidRes.45,378(2004)
  6. Selectivityofmicrobialacyl-CoA:cholesterolacyltransferaseinhibitorstowardisozymes:T.Ohshiro,etal.;J.Antibiot.(Tokyo)60,43(2007)
  7. Potentialtherapeuticsforobesityandatherosclerosis:inhibitorsofneutrallipidmetabolismfrommicroorganisms:H.Tomoda&S.Omura;Pharmacol.Ther.115,375(2007)(Review)
  8. Identificationoftheinteractionsitewithinacyl-CoA:cholesterolacyltransferase2fortheisoform-specificinhibitorpyripyropeneA:A.Das,etal.;J.Biol.Chem.283,10453(2008)
  9. Selectivityofpyripyropenederivativesininhibitiontowardacyl-CoA:cholesterolacyltransferase2isozyme:T.Ohshiro,etal.;J.Antibiot.(Tokyo).61,503(2008)
  10. Pyripyropenes,fungalsesquiterpenesconjugatedwithalpha-pyroneandpyridinemoieties,exhibitsanti-angiogenicactivityagainsthumanumbilicalveinendothelialcells:A.Hayashi,etal.;Biol.Pharm.Bull.32,1261(2009)
  11. PyripyropeneA,anacyl-coenzymeA:cholesterolacyltransferase2-selectiveinhibitor,attenuateshypercholesterolemiaandatherosclerosisinmurinemodelsofhyperlipidemia:T.Ohshiro,etal.;Arterioscler.Thromb.Vasc.Biol.31,1108(2011)
  12. Isoform-specificinhibitorsofACATs:recentadvancesandpromisingdevelopments:T.Ohshiro&H.Tomoda;FutureMed.Chem.3,2039(2011)(Review)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。